EP 3083594 A1 20161026 - SUBSTITUTED BIPIPERIDINYL DERIVATIVES AS ADRENORECEPTOR ALPHA 2C ANTAGONISTS
Title (en)
SUBSTITUTED BIPIPERIDINYL DERIVATIVES AS ADRENORECEPTOR ALPHA 2C ANTAGONISTS
Title (de)
SUBSTITUIERTE BIPIPERIDINYL-DERIVATE ALS ADRENOREZEPTOR ALPHA 2C ANTAGONISTEN
Title (fr)
UTILISATION DE DÉRIVÉS DE BIPIPÉRIDINYLE SUBSTITUÉS COMME ANTAGONISTES DES ALPHA-2C-ADRÉNORÉCEPTEURS
Publication
Application
Priority
- EP 13198389 A 20131219
- EP 14192876 A 20141112
- EP 2014077863 W 20141216
- EP 14815662 A 20141216
Abstract (en)
[origin: WO2015091415A1] The invention relates to novel substituted bipiperidinyl derivatives, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of diabetic microangiopathies, diabetic ulcers on the extremities, especially for promotion of wound healing of diabetic foot ulcers, diabetic heart failure, diabetic coronary microvascular heart disorders, peripheral and cardiac vascular disorders, thromboembolic disorders and ischaemias, peripheral circulation disorders, Raynaud phenomena, CREST syndrome, microcirculation disorders, intermittent claudication, and peripheral and autonomous neuropathies.
IPC 8 full level
C07D 401/14 (2006.01); A61K 31/4468 (2006.01); A61K 31/4523 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); C07D 211/16 (2006.01); C07D 211/22 (2006.01); C07D 211/42 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 413/04 (2006.01); C07D 413/10 (2006.01); C07D 413/12 (2006.01)
CPC (source: EP US)
A61K 31/4545 (2013.01 - US); A61K 45/06 (2013.01 - US); A61P 1/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 211/10 (2013.01 - EP US); C07D 211/16 (2013.01 - EP US); C07D 211/22 (2013.01 - EP US); C07D 211/42 (2013.01 - EP US); C07D 211/60 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 401/14 (2013.01 - EP US); C07D 403/04 (2013.01 - EP US); C07D 405/14 (2013.01 - EP US); C07D 413/04 (2013.01 - EP US); C07D 413/10 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US); C07D 413/14 (2013.01 - EP US)
Citation (search report)
See references of WO 2015091415A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015091415 A1 20150625; CA 2934132 A1 20150625; CN 106029648 A 20161012; EP 3083594 A1 20161026; JP 2017503783 A 20170202; US 2016318866 A1 20161103
DOCDB simple family (application)
EP 2014077863 W 20141216; CA 2934132 A 20141216; CN 201480075950 A 20141216; EP 14815662 A 20141216; JP 2016540673 A 20141216; US 201415106285 A 20141216